Akso Health Group
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 133.0
- Dividend yield
- –
About Akso Health
Services-Business Services, NEC, SIC 7389
Akso Health Group operates as a holding company that provides social e-commerce services, marketing promotion services, and healthcare-related offerings. Through its operating subsidiaries, the company runs the Xiaobai Maimai application, facilitating online retail transactions across partner e-commerce platforms and service marketplaces. It also engages in marketing promotion services and the distribution of medical devices under specialized operational licenses. Additionally, the company provides health management, outpatient clinic, and remote medical consultation services. Its customer base consists of individual retail consumers, platform members, merchants, and healthcare patrons.
The company conducts its business operations primarily in China and the United States. Its principal executive offices are located in Qingdao, Shandong Province, China, while the holding company is incorporated in the Cayman Islands. Its operating network includes multiple operating subsidiaries and healthcare facilities across mainland China and the United States, alongside business entities situated in Hong Kong.
Summary of the business section of Akso Health's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Akso Health Group
- Founded
- 2016
- Headquarters
- Qingdao Pilot Free Trade Zone, F4
- Address
- Rm 8201-4-4(A) 2nd Floor Qiantongyua Bld, No. 44 Moscow Rd Qianwan Bonded Port Are 0000
- Phone
- 86 152 1005 4919
- Employees
- 12, Mar 31, 2026
- Industry
- Services-Business Services, NEC
- Incorporated in
- E9
- Fiscal year ends
- March 31
- Auditor
- CHI-LLTC, Perak, Malaysia
Stock & identifiers
- Ticker
- AHG
- Exchange
- Nasdaq
- IPO date
- Oct 25, 2017
- Shares outstanding
- 2.57B, Mar 31, 2026
- Filer category
- Large accelerated filer
- Stock splits
- 1-for-3 reverse, Aug 24, 2020
- SEC CIK
- 1702318
- CUSIP
- 98422P108
- ISIN
- US98422P1084
- LEI
- 5493007BHBTZESVSIA24
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Zhongliang Xie | Director | – |
| Jianqiang Xu | Director | – |
| Wenjuan Liu | Director | – |
| Stephen P. Brown | Director | – |
| Yilin Wang | Director | – |
| Zhe Liu | Director | – |
Employees
Headcount reported in annual reports
“We had 9, 27 and 12 full-time employees as of March 31, 2024, 2025 and 2026, respectively.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Jul 31, 2025 | Late filing | Notification of late filing |
| Aug 1, 2022 | Late filing | Notification of late filing |
| Dec 17, 2021 | Name change | Name changed from Xiaobai Maimai Inc. to Akso Health Group |
| Dec 21, 2020 | Name change | Name changed from Hexindai Inc. to Xiaobai Maimai Inc. |
| Aug 3, 2020 | Late filing | Notification of late filing |
| Oct 25, 2017 | IPO | Initial public offering priced (424B4 prospectus) |
| Oct 16, 2017 | Listing | Registration of securities on an exchange (Form 8-A) |